The Linkou Chang Gung Memorial Hospital also known as Chang Gung Memorial Hospital or "Chang Gung Hospital", is a hospital located in Guishan District, Taoyuan City, Taiwan. It is part of the Chang Gung Medical Foundation hospital network.

During the past decade, Chang Gung Medical Foundation conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang Gung Medical Foundation" #1 sponsor was "Chang Gung Memorial Hospital" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Exact Sciences Corporation" with 1 trials sponsored, "National Taiwan University Hospital" with 1 trials sponsored and "NaviFUS Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Medical Foundation" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator and "Virginia Contract Research Organization Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Medical Foundation" are "Dementia" (2 trials), "B-cell Lymphoma" (1 trials), "Breast Cancer" (1 trials), "Critical Illness" (1 trials) and "Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Chang Gung Medical Foundation" in a lesser frequency.

Most popular intervention types in "Chang Gung Medical Foundation" are "Drug" (3 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials), "Blood Sample Collection" (1 trials), "CHOP" (1 trials) and "Critical Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Medical Foundation" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Chang Gung Medical Foundation". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chang Gung Medical Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Medical Foundation, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".